Search by Drug Name, NDC or Jcode
J-Code Lookup
Last Jcode file upload: 1/24/2024
How To Use This Tool
This tool allows you to search for the details of a J-code in several ways, including:
- Drug Name (currently only searching by the generic drug name is supported)
- HCPCS Code
- NDC
For example, you can look up a J-code by NDC. Simply type the NDC into the search box.
Most J-code detail pages contain a complete HCPCS/NDC crosswalk.
***IMPORTANT: Search results will appear at the bottom of the page***
What Is This Tool?
Our J-Code lookup tool allows you to find all of the HCPCS (Healthcare Common Procedure Coding System) J-code (and Q-code) drugs and their respective HCPCS Details. In addition, each detail page contains an HCPCS/NDC crosswalk, a billing calculator, and drug information.
One of the more popular features of this tool is that it allows you to look up a Jcode by NDC OR by a drug name.
What Are J-Codes & Q-Codes?
'J-codes' are drugs that are typically billed through a 'medical' benefit versus a 'pharmacy' benefit under health plans, and are generally not self-administered (i.e. are administered by a health care professional). They consist of chemotherapy drugs and injectable drugs:
- J0120-J8999 - Drugs Administered Other than Oral Method
- J9000-J9999 - Chemotherapy Drugs
Q-Codes are simply temporary codes that the Centers for Medicare & Medicaid Services (CMS) establish for services and supplies that do not yet have a permanent code.
J-codes and Q-codes are part of the HCPCS Level II code set used for billing for drugs (primarily injectables), supplies, equipment, nonphysician services, and services not represented by CPT codes (Level I HCPCS). They are often billed along with a procedure-based CPT code.
Additional Information
This tool is free to use but its contents are not available for download or reproduction.
JCode Directory
| HCPC | Drug name |
|---|---|
| Q0163 | Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen |
| Q0164 | Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0166 | Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen |
| Q0167 | Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0169 | Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0173 | Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0174 | Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0175 | Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0177 | Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0180 | Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen |
| Q0181 | Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
| Q0220 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromis |
| Q0221 | Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromis |
| Q0222 | Injection, bebtelovimab, 175 mg |
| Q0239 | Injection, bamlanivimab-xxxx, 700 mg |
| Q0240 | Injection, casirivimab and imdevimab, 600 mg |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg |
| Q0244 | Injection, casirivimab and imdevimab, 1200 mg |
| Q0245 | Injection, bamlanivimab and etesevimab, 2100 mg |
| Q0247 | Injection, sotrovimab, 500 mg |
| Q0249 | Injection, tocilizumab, for hospitalized adults and pediatric patients (2 years of age and older) with covid-19 who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal |
| Q0477 | Power module patient cable for use with electric or electric/pneumatic ventricular assist device, replacement only |
| Q0478 | Power adapter for use with electric or electric/pneumatic ventricular assist device, vehicle type |
| Q0479 | Power module for use with electric or electric/pneumatic ventricular assist device, replacement only |
| Q0480 | Driver for use with pneumatic ventricular assist device, replacement only |
| Q0481 | Microprocessor control unit for use with electric ventricular assist device, replacement only |
| Q0482 | Microprocessor control unit for use with electric/pneumatic combination ventricular assist device, replacement only |
| Q0483 | Monitor/display module for use with electric ventricular assist device, replacement only |
| Q0484 | Monitor/display module for use with electric or electric/pneumatic ventricular assist device, replacement only |
| Q0485 | Monitor control cable for use with electric ventricular assist device, replacement only |